Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,145 public trials 553 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

NCT00002097

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Twelve Oaks Hosp Houston, Texas, United States

View Trial Details

Completed

A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia

NCT00002317

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: United States Bioscience Inc West Conshohocken, Pennsylvania, United States

View Trial Details

Completed

A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus

NCT00002287

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States

View Trial Details

Completed

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

NCT00002378

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: ASC Inc Anniston, Alabama, United States

CIGNA Phoenix, Arizona, United States

Arizona Clinical Research Ctr Inc Tucson, Arizona, United States

Univ of Arizona Tucson, Arizona, United States

View all 102 locations

View Trial Details

Completed

A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

NCT00000890

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States

Univ of California / San Diego Treatment Ctr San Diego, California, United States

Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco, California, United States

Stanford Univ Med Ctr Stanford, California, United States

View all 21 locations

View Trial Details

Completed

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

NCT00004852

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Phoenix Body Positive Phoenix, Arizona, United States

Pacific Oaks Research Beverly Hills, California, United States

AIDS Healthcare Foundation Los Angeles, California, United States

Tower ID Med Associates Los Angeles, California, United States

View all 66 locations

View Trial Details

Completed

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

NCT00002199

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States

View Trial Details

Completed

The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before

NCT00002291

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +25 more
Locations: Fisons Corp Rochester, New York, United States

View Trial Details

Completed

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

NCT00002245

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +16 more
Locations: LAC / USC Med Ctr / Infectious Diseases Los Angeles, California, United States

View Trial Details

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Stanford Univ Med Ctr Stanford, California, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions